Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04454281 · ClinicalTrials.gov registry record · Phase 1
Topical Naloxone to Diagnose Ocular Pain
A Phase 1 study of Neuropathic Pain and Dry Eye Syndromes, sponsored by Seema Capoor.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT04454281 is a Phase 1 study of Neuropathic Pain and Dry Eye Syndromes that has completed, run by Seema Capoor. The registered enrollment target is 1 participants, below the 101-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04454281, a Phase 1 study of Neuropathic Pain and Dry Eye Syndromes, has completed, sponsored by Seema Capoor.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic ocular neuropathic pain may be misdiagnosed as dry eye disease. Our study aims to identify a population with previous monocular trauma and dry eye symptoms and differentiate neuropathic from dry eye pain using topical corneal naloxone hydrochloride.
Conditions Studied
Interventions
- DRUG Naloxone Hydrochloride 0.4 MG/ML
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2020-12-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04454281
The ClinicalTrials.gov registry entry for NCT04454281 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (99% lower). The listed sponsor is Seema Capoor, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neuropathic Pain appearing as the primary indexed condition, and to 1 intervention - of which Naloxone Hydrochloride 0.4 MG/ML is the first listed.
NCT04454281 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04454281 about?
NCT04454281 is a clinical study titled "Topical Naloxone to Diagnose Ocular Pain". Chronic ocular neuropathic pain may be misdiagnosed as dry eye disease. Our study aims to identify a population with previous monocular trauma and dry eye symptoms and differentiate neuropathic from dry eye pain using topical corneal naloxone hydrochloride.
What is the current status of trial NCT04454281?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2020-10-01. Estimated completion is 2020-12-03.
What conditions does trial NCT04454281 study?
This clinical trial studies the following conditions: Neuropathic Pain, Dry Eye Syndromes.
What interventions are being tested in trial NCT04454281?
The interventions under investigation include: Naloxone Hydrochloride 0.4 MG/ML (DRUG).
Who is sponsoring clinical trial NCT04454281?
This trial is sponsored by Seema Capoor, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04454281 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
RECRUITING · Phase 1
-
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
RECRUITING · Phase 1
-
Effects of Smoked Marijuana on Neuropathic Pain
COMPLETED · Phase 1
-
Tariquidar-ondansetron Combination in Neuropathic Pain
COMPLETED · Phase 1
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.